Furthermore, the activation of these growth factors and MAPK (MEK-ERK) pathway, an intercellular signaling pathway involved in cell growth located downstream of their receptors, may lead to an increase in the production of glioma cells47. This evidence concerns the gene MAPK1 and central nervous system cancer.